After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.

WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive ...

MIT scientists have developed polymer microparticles that release vaccine doses over time, offering a single-shot solution ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The Trump administration plans to drop routine COVID vaccination guidance for kids and pregnant women, marking a major shift ...

The first human clinical trials testing a new strategy to protect against HIV infections have yielded promising early results ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.